{"id":"placebo-of-test-product","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL3039083","moleculeType":"Small molecule","molecularWeight":"648.66"},"_fixedAt":"2026-03-30T12:35:19.095123","_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Placebos are inert formulations used in randomized controlled trials to establish the true efficacy of an investigational drug by comparison against a non-active control. This placebo is specifically formulated to match the test product's characteristics to maintain blinding integrity in the phase 3 trial.","oneSentence":"A placebo control product designed to match the appearance and administration route of FLUIDDA's test product for blinded clinical comparison.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:28:14.106Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"_fixedFields":["pubmed(108)"],"trialDetails":[{"nctId":"NCT05377424","phase":"PHASE1, PHASE2","title":"Adenosine 2A Receptor Antagonism and AIH in ALS","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Florida","startDate":"2022-06-21","conditions":"ALS","enrollment":40},{"nctId":"NCT07498712","phase":"NA","title":"Effect of L. Reuteri LM1063 on Sleep Health Improvement","status":"RECRUITING","sponsor":"Lactomason Co., Ltd.","startDate":"2025-07-14","conditions":"Sleep Quality, Sleep Wake Disorders","enrollment":80},{"nctId":"NCT05564390","phase":"PHASE2","title":"MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2024-06-18","conditions":"Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm, Acute Myeloid Leukemia Post Cytotoxic Therapy","enrollment":2000},{"nctId":"NCT04172532","phase":"PHASE1, PHASE2","title":"Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2021-01-11","conditions":"Locally Advanced Pancreatic Adenocarcinoma, Stage III Pancreatic Cancer AJCC v8","enrollment":92},{"nctId":"NCT03914612","phase":"PHASE3","title":"Testing the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2019-08-22","conditions":"Endometrial Clear Cell Adenocarcinoma, Endometrial Dedifferentiated Carcinoma, Endometrial Endometrioid Adenocarcinoma","enrollment":813},{"nctId":"NCT07492771","phase":"PHASE1","title":"MP101 in Adults With Acute Pseudomonas Aeruginosa Pneumonia","status":"NOT_YET_RECRUITING","sponsor":"MicrobiotiX Co., Ltd","startDate":"2026-03","conditions":"Pneumonia - Bacterial, Pseudomonas Aeruginosa Infection","enrollment":18},{"nctId":"NCT06247345","phase":"PHASE1","title":"A Phase Ia/Ib, First-in-human (FIH) Study for Safety, Tolerability, Pharmacokinetics (PK), and Clinical Activity Evaluation of ADEL-Y01","status":"SUSPENDED","sponsor":"Alzheimer's Disease Expert Lab (ADEL), Inc.","startDate":"2024-02-06","conditions":"Alzheimer Disease","enrollment":73},{"nctId":"NCT07482046","phase":"PHASE2, PHASE3","title":"Effectiveness of Topical Menthol as A Cooling Method During Exercise in A Recreational Runner Population","status":"COMPLETED","sponsor":"Taisho Pharmaceutical Indonesia","startDate":"2023-05-30","conditions":"Heat Stress, Athletic Performance","enrollment":37},{"nctId":"NCT06406114","phase":"PHASE2","title":"Optimizing the Diagnostic Approach to Cephalosporin Allergy Testing","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2025-05-05","conditions":"Drug Allergy, Cephalosporin Allergy, Drug Hypersensitivity","enrollment":300},{"nctId":"NCT06946290","phase":"NA","title":"Intertransverse Process Block to Improve Quality of Recovery and Pain Management in Adult Cardiac Surgical Patients","status":"RECRUITING","sponsor":"Chinese University of Hong Kong","startDate":"2026-01-02","conditions":"Chronic Postsurgical Pain","enrollment":96},{"nctId":"NCT03468556","phase":"PHASE2","title":"A Randomized, Double-Blind, Placebo Controlled Study to Assess the Efficacy and Safety of SNP-610 for the Treatment of Patients With Non-alcoholic Steatohepatitis","status":"NOT_YET_RECRUITING","sponsor":"Sinew Pharma Inc.","startDate":"2026-04-01","conditions":"NASH - Nonalcoholic Steatohepatitis","enrollment":80},{"nctId":"NCT07473752","phase":"PHASE1","title":"A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TNX-1500 in Healthy Subjects","status":"COMPLETED","sponsor":"Tonix Pharmaceuticals, Inc.","startDate":"2023-07-18","conditions":"Phase 1 First-in-human Study Involving Healthy Subjects","enrollment":26},{"nctId":"NCT03947216","phase":"PHASE2","title":"Randomized Placebo Controlled Trial Evaluating the Efficacy of Pimavanserin, a Selective Serotonin 5-HydroxyTryptamine-2A (5HT2A) Inverse Agonist, to Treat Impulse Control Disorders in Parkinson's Disease.","status":"COMPLETED","sponsor":"University Hospital, Strasbourg, France","startDate":"2020-10-23","conditions":"Parkinson Disease","enrollment":117},{"nctId":"NCT00663611","phase":"PHASE1","title":"Growth Hormone Administration and the Human Immune System","status":"COMPLETED","sponsor":"National Institute on Aging (NIA)","startDate":"2006-10-19","conditions":"Healthy Volunteers","enrollment":66},{"nctId":"NCT07469228","phase":"PHASE1","title":"A Study Comparing Tretinoin Gel Microsphere, 0.04% and RETIN-A MICRO ® Gel Microsphere, 0.04% in the Treatment of Acne Vulgaris","status":"COMPLETED","sponsor":"Sun Pharmaceutical Industries, Inc.","startDate":"2025-08-04","conditions":"Acne Vulgaris","enrollment":1043},{"nctId":"NCT06365892","phase":"NA","title":"Open-label Placebo (COLP) for Pain in Adolescent Idiopathic Scoliosis (AIS) Surgery+Surgical Treatment of Idiopathic Scoliosis","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2024-07-01","conditions":"Adolescent Idiopathic Scoliosis (AIS)","enrollment":64},{"nctId":"NCT05856526","phase":"PHASE2, PHASE3","title":"A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Netherton Syndrome","status":"TERMINATED","sponsor":"Boehringer Ingelheim","startDate":"2023-06-12","conditions":"Netherton Syndrome","enrollment":43},{"nctId":"NCT07467746","phase":"PHASE2","title":"Research of Traditional Chinese Medicine Oral Preparation of C. Cicadae in the Treatment of ALS Patients With Elevated Plasma Sphingolipids","status":"NOT_YET_RECRUITING","sponsor":"The Third Xiangya Hospital of Central South University","startDate":"2026-04","conditions":"Amyotrophic Lateral Sclerosis","enrollment":84},{"nctId":"NCT04192136","phase":"NA","title":"NAD+ and Exercise in FA","status":"COMPLETED","sponsor":"Children's Hospital of Philadelphia","startDate":"2020-09-03","conditions":"Friedreich Ataxia 1","enrollment":75},{"nctId":"NCT06899815","phase":"PHASE1","title":"Preliminary Human Trials of F230 Tablets","status":"RECRUITING","sponsor":"Beijing Continent Pharmaceutical Co, Ltd.","startDate":"2025-05-15","conditions":"Pulmonary Hypertension","enrollment":136},{"nctId":"NCT04862221","phase":"PHASE2","title":"TReatment for ImmUne Mediated PathopHysiology","status":"RECRUITING","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2022-02-09","conditions":"Acute Liver Failure, Fulminant Hepatic Failure, Hepatic Encephalopathy","enrollment":163},{"nctId":"NCT05378334","phase":"NA","title":"Efficacy and Safety of HGXJT in Bone Metastatic NSCLC Patients","status":"RECRUITING","sponsor":"Guangzhou University of Traditional Chinese Medicine","startDate":"2022-06-15","conditions":"Non-small Cell Lung Cancer","enrollment":82},{"nctId":"NCT06654089","phase":"PHASE4","title":"A Study Evaluating Quality of Life Parameters Following Use of Emergen-C","status":"COMPLETED","sponsor":"HALEON","startDate":"2024-10-30","conditions":"Dietary Supplements","enrollment":299},{"nctId":"NCT05367362","phase":"PHASE2","title":"Minocycline Efficacy in Improving Neurological Outcome of Patients Who Undergo Endovascular Revascularization for Acute Ischemic Stroke","status":"WITHDRAWN","sponsor":"State University of New York at Buffalo","startDate":"2025-12-01","conditions":"Acute Ischemic Stroke","enrollment":""},{"nctId":"NCT07456813","phase":"NA","title":"Clinical Study on Guben Kechuan Granules Promoting Disease Recovery by Regulating Immune-Inflammatory Dysregulation in Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease During the Peri-Discharge Period","status":"NOT_YET_RECRUITING","sponsor":"Cuiling Feng","startDate":"2026-03-15","conditions":"Chronic Obstructive Pulmonary Disease (COPD)","enrollment":126},{"nctId":"NCT06575075","phase":"PHASE1, PHASE2","title":"Pilot Study of RR-HNK in OCD","status":"RECRUITING","sponsor":"Carolyn Rodriguez","startDate":"2026-01-23","conditions":"Obsessive-Compulsive Disorder","enrollment":45},{"nctId":"NCT07229911","phase":"PHASE1","title":"A Study of TAK-781 in Healthy Volunteers and in Participants With Non-Cirrhotic Primary Sclerosing Cholangitis (PSC)","status":"RECRUITING","sponsor":"Takeda","startDate":"2026-01-07","conditions":"Healthy Volunteers, Primary Sclerosing Cholangitis","enrollment":134},{"nctId":"NCT07446361","phase":"NA","title":"A Study to Evaluate the Efficacy of Collagen 16 Serum Alone, Against and as an Adjunct to Radiesse® Biostimulation Procedure in Female Trial Participants With Aged Skin","status":"NOT_YET_RECRUITING","sponsor":"Vichy Laboratoires","startDate":"2026-03-01","conditions":"Wrinkle Appearance, Skin Quality","enrollment":180},{"nctId":"NCT07049055","phase":"PHASE1, PHASE2","title":"A Clinical Trial to Evaluate EDV Nanocell Therapy With Gemcitabine and Nab-paclitaxel in Pancreatic Cancer","status":"RECRUITING","sponsor":"Engeneic Pty Limited","startDate":"2026-01-12","conditions":"Pancreatic Cancer, Metastatic, PDAC - Pancreatic Ductal Adenocarcinoma","enrollment":144},{"nctId":"NCT06578247","phase":"PHASE3","title":"Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML","status":"RECRUITING","sponsor":"Daiichi Sankyo","startDate":"2024-11-19","conditions":"Leukemia","enrollment":700},{"nctId":"NCT07429565","phase":"PHASE1","title":"Testing APPA-1 in Healthy Subjects and Osteoarthritis Patients","status":"COMPLETED","sponsor":"University of Liverpool","startDate":"2018-04-09","conditions":"Osteoarthritis","enrollment":40},{"nctId":"NCT05677113","phase":"PHASE2","title":"A Study of QBECO Versus Placebo in the Treatment of Colorectal Cancer That Has Spread to the Liver","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2023-08-01","conditions":"Colorectal Cancer, Liver Metastases","enrollment":115},{"nctId":"NCT05134441","phase":"PHASE3","title":"Study to Evaluate the Efficacy, Safety, and Tolerability of IMU-838 in Patients With Relapsing Multiple Sclerosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Immunic AG","startDate":"2021-11-18","conditions":"Multiple Sclerosis","enrollment":1121},{"nctId":"NCT05201638","phase":"PHASE3","title":"Study to Evaluate the Efficacy, Safety and Tolerability of IMU-838 in Patients With Relapsing Multiple Sclerosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Immunic AG","startDate":"2022-01-12","conditions":"Multiple Sclerosis, Relapsing-Remitting","enrollment":1100},{"nctId":"NCT07282756","phase":"NA","title":"Evaluation Of The Efficacy Of Subgingival Application Of Lovastatin Gel As An Adjunct To Non-Surgical Treatment Of Periodontitis In Generally Healthy Smokers And Non-Smokers Patients in Central Europe.","status":"RECRUITING","sponsor":"Medical University of Silesia","startDate":"2025-07-11","conditions":"Periodontal Diseases, Periodontitis, Periodontal Disease","enrollment":44},{"nctId":"NCT04555434","phase":"PHASE1, PHASE2","title":"Effects of Probiotics (P. Pentosaceus, L. Lactis or L. Helveticus) in NASH","status":"COMPLETED","sponsor":"Chuncheon Sacred Heart Hospital","startDate":"2020-09-20","conditions":"Non-Alcoholic Fatty Liver Disease, MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease","enrollment":89},{"nctId":"NCT06125951","phase":"PHASE2, PHASE3","title":"Effect of 10 mg Xanamem on Dementia Due to Alzheimer's Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"Actinogen Medical","startDate":"2024-04-12","conditions":"Dementia Moderate, Dementia, Mild, Alzheimer Disease","enrollment":247},{"nctId":"NCT07059091","phase":"PHASE2","title":"Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2026-02-12","conditions":"Chronic Obstructive Pulmonary Disease (COPD), Allergies","enrollment":334},{"nctId":"NCT04606316","phase":"PHASE1","title":"Surgical Nivolumab And Ipilimumab For Recurrent GBM","status":"ACTIVE_NOT_RECRUITING","sponsor":"Patrick Wen, MD","startDate":"2021-02-01","conditions":"Glioblastoma, GBM, Glioblastoma Multiforme","enrollment":63},{"nctId":"NCT06695962","phase":"PHASE3","title":"Efficacy of Domperidone (a Prokinetic Agent) on Time in Range in Digestively Asymptomatic Type I Diabetic Patients With Delayed Gastric Emptying (Gastro-TIR)","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Rouen","startDate":"2026-03-01","conditions":"Type 1 Diabetic","enrollment":70},{"nctId":"NCT07286487","phase":"NA","title":"Glycyrrhetinic Acid and Acute Irritant Dermatitis","status":"NOT_YET_RECRUITING","sponsor":"University of Split, School of Medicine","startDate":"2026-03-01","conditions":"Irritant Contact Dermatitis","enrollment":30},{"nctId":"NCT07408518","phase":"NA","title":"Impact of B. Adolescentis iVS-1 Probiotic on Gastrointestinal Outcomes","status":"RECRUITING","sponsor":"Synbiotic Health","startDate":"2026-01-20","conditions":"Digestive Disease, Gut Health","enrollment":92},{"nctId":"NCT05954286","phase":"PHASE2","title":"PROTECT-APT 1: Early Treatment and Post-Exposure Prophylaxis of COVID-19","status":"COMPLETED","sponsor":"Henry M. Jackson Foundation for the Advancement of Military Medicine","startDate":"2024-01-29","conditions":"SARS-CoV-2","enrollment":92},{"nctId":"NCT07411378","phase":"PHASE2","title":"Testing the Efficacy, Safety, and PK of 20E in Patients With Obesity Who Are Starting Treatment With the GLP-1 Agonist Semaglutide for Weight Loss.","status":"NOT_YET_RECRUITING","sponsor":"Biophytis","startDate":"2026-07","conditions":"Muscle Wasting, Obesity & Overweight, Obesity","enrollment":164},{"nctId":"NCT07280858","phase":"PHASE1, PHASE2","title":"A Phase I/II, Dose-finding Study to Assess the Safety, Reactogenicity, and Immunogenicity of a Broadly Protective Sarbecovirus Vaccine (GBP511) in Healthy Adults.","status":"RECRUITING","sponsor":"SK Bioscience Co., Ltd.","startDate":"2026-01-28","conditions":"Healthy Participants, Sarbecovirus","enrollment":368},{"nctId":"NCT07407634","phase":"EARLY_PHASE1","title":"A Randomized, Double-blind, Single-center Phase I/IIa Study of XTYW007 Tablets in Subjects.","status":"NOT_YET_RECRUITING","sponsor":"Xi'an Xintong Pharmaceutical Research Co.,Ltd.","startDate":"2026-03-25","conditions":"Non-Alcoholic Fatty Liver Disease","enrollment":94},{"nctId":"NCT07400471","phase":"EARLY_PHASE1","title":"The Effects of Preemptive Multimodal Analgesic on Endodontic Pain Following Root Canal Therapy.","status":"RECRUITING","sponsor":"Chattogram International Dental College","startDate":"2026-02-06","conditions":"Post Endodontic Pain, Mechanical Detection Threshold, Mechanical Pain Threshold","enrollment":280},{"nctId":"NCT07403942","phase":"NA","title":"The Skin Anti-Aging Effects of Vitamin K2 (MK-7): a Clinical Split-Face/Neck Trial","status":"COMPLETED","sponsor":"Nanjing Ascend Biotech Technology Co., Ltd.","startDate":"2024-12-26","conditions":"Skin Aging of Face and Neck","enrollment":36},{"nctId":"NCT07400367","phase":"NA","title":"Impact of a Probiotic Supplementation With Lifestyle Modification on Liver Steatosis, Fibrosis, and Metabolic Health in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)","status":"NOT_YET_RECRUITING","sponsor":"Fu Jen Catholic University Hospital","startDate":"2026-02","conditions":"Liver Elastography, Liver Steatosis, Liver Function Test","enrollment":80},{"nctId":"NCT02162849","phase":"PHASE4","title":"Reward Sensitivity and Pharmacotherapy for Smoking Cessation","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2015-12-14","conditions":"Tobacco Use Cessation","enrollment":204},{"nctId":"NCT07396610","phase":"NA","title":"Effect of Diode Laser and Bioactive Glass on Dentinal Hypersensitivity","status":"COMPLETED","sponsor":"King Khalid University","startDate":"2025-01-01","conditions":"Dentinal Hypersensitivity","enrollment":100},{"nctId":"NCT07393126","phase":"NA","title":"Effects of the Consumption of Test Product on Urination in Healthy Japanese Adults","status":"RECRUITING","sponsor":"Indena S.p.A","startDate":"2025-12-08","conditions":"Healthy Japanese","enrollment":76},{"nctId":"NCT07393802","phase":"PHASE3","title":"Evaluation of the Anti-Plaque Effect of a Resveratrol-Based Mouthwash Using a 24-Hour Plaque Re-Growth","status":"NOT_YET_RECRUITING","sponsor":"University of Baghdad","startDate":"2026-03","conditions":"Mouthwash, Chlorhexidine, Biofilm Formation","enrollment":20},{"nctId":"NCT06961019","phase":"NA","title":"Clinical Study to Assess the Safety, Efficacy and In-Use Tolerability of Herbal-Based Sugar Support Effervescent Tablets in Type-2 Diabetes Mellitus Patients","status":"RECRUITING","sponsor":"NovoBliss Research Pvt Ltd","startDate":"2025-08-25","conditions":"Type2 Diabetes Mellitus","enrollment":14},{"nctId":"NCT07215767","phase":"PHASE3","title":"Clinical Study to Investigate the Antihypersensitivity Efficacy of a Novel Dentifrice","status":"RECRUITING","sponsor":"HALEON","startDate":"2025-09-16","conditions":"Dentin Hypersensitivity","enrollment":850},{"nctId":"NCT06532279","phase":"PHASE2","title":"Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer","status":"RECRUITING","sponsor":"NRG Oncology","startDate":"2024-12-16","conditions":"Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8","enrollment":98},{"nctId":"NCT04705220","phase":"NA","title":"Effect of Nutritional Supplementation With Turmeric on the Cognitive Performance of Subjects With Metabolic Syndrome","status":"COMPLETED","sponsor":"Indena S.p.A","startDate":"2022-04-08","conditions":"Mild Cognitive Impairment","enrollment":85},{"nctId":"NCT07142720","phase":"NA","title":"Rapid Effects on Antioxidant Status, Immune Alertness, and Regenerative Activity","status":"COMPLETED","sponsor":"Natural Immune Systems Inc","startDate":"2022-11-01","conditions":"Immune Surveillance, Stem Cell Surveillance","enrollment":20},{"nctId":"NCT07162623","phase":"NA","title":"Clinical Study to Assess Safety, Efficacy and In-Use Tolerability of Oziva Bioactive Gluta Fizzy Effervescent Tablets on Subjects With Facial Dark Spots Such as Pimple Marks, Sunspots, Age Spots and Uneven Skin Tone","status":"ACTIVE_NOT_RECRUITING","sponsor":"NovoBliss Research Pvt Ltd","startDate":"2025-09-02","conditions":"Hyperpigmentation","enrollment":60},{"nctId":"NCT07379333","phase":"PHASE3","title":"A Study to Evaluate Efficacy and Safety of HM11260C in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and Dapagliflozin","status":"NOT_YET_RECRUITING","sponsor":"Hanmi Pharmaceutical Company Limited","startDate":"2026-02","conditions":"Type 2 Diabetes","enrollment":118},{"nctId":"NCT01478152","phase":"NA","title":"Effect of Ectoin® Inhalation Solution on Subjects With Mild Bronchial Asthma","status":"COMPLETED","sponsor":"Bitop AG","startDate":"2009-08","conditions":"Asthma","enrollment":18},{"nctId":"NCT05697640","phase":"PHASE2","title":"Study to Investigate Improvement in Physical Function in SF-36 With Vericiguat Compared With Placebo in Participants With Post-COVID-19 Syndrome","status":"ACTIVE_NOT_RECRUITING","sponsor":"Charite University, Berlin, Germany","startDate":"2023-06-22","conditions":"Post-COVID ME/CFS","enrollment":104},{"nctId":"NCT05063201","phase":"PHASE2","title":"Cariprazine for Comorbid Cocaine and Opioid Use Disorder","status":"COMPLETED","sponsor":"Kyle Kampman","startDate":"2022-08-05","conditions":"Opioid-use Disorder, Cocaine Use Disorder","enrollment":26},{"nctId":"NCT05028062","phase":"PHASE4","title":"Naltrexone in AUD Reward Drinkers","status":"RECRUITING","sponsor":"University of Pennsylvania","startDate":"2022-03-07","conditions":"Alcohol Use Disorder, Alcoholism","enrollment":60},{"nctId":"NCT07346690","phase":"PHASE1","title":"A Study Testing the Effects of Different THC Doses on Psychological and Biological Function","status":"NOT_YET_RECRUITING","sponsor":"University of Calgary","startDate":"2026-02-01","conditions":"Evaluate PK Profile, Evaluate PD Profile, Healthy Adults","enrollment":24},{"nctId":"NCT07345195","phase":"NA","title":"The Effect of 16-week Dietary Intake of Food Supplements Containing Collagen and MSM on Facial Erythema and Other Skin Parameters","status":"NOT_YET_RECRUITING","sponsor":"VIST - Faculty of Applied Sciences","startDate":"2026-01","conditions":"Erythema, Telangiectasis, Skin Redness","enrollment":90},{"nctId":"NCT07307274","phase":"PHASE1","title":"A Study of SYNT-101 to Test Safety, Tolerability and Pharmacodynamics of SYNT-101 in Healthy and Overweight Adults","status":"RECRUITING","sponsor":"Syntis Bio","startDate":"2026-01-05","conditions":"Healthy, Overweight and Obese Adults","enrollment":64},{"nctId":"NCT01988883","phase":"EARLY_PHASE1","title":"Modafinil and Cognitive Function in POTS","status":"ACTIVE_NOT_RECRUITING","sponsor":"Vanderbilt University Medical Center","startDate":"2014-10","conditions":"Postural Tachycardia Syndrome","enrollment":20},{"nctId":"NCT07341178","phase":"NA","title":"Acute Effects on Stem Cell Surveillance","status":"NOT_YET_RECRUITING","sponsor":"Natural Immune Systems Inc","startDate":"2026-01","conditions":"Stem Cell Surveillance","enrollment":48},{"nctId":"NCT05053152","phase":"PHASE2","title":"Testing the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer, The NRG Promethean Study","status":"RECRUITING","sponsor":"NRG Oncology","startDate":"2022-04-20","conditions":"Oligometastatic Prostate Carcinoma, Prostate Adenocarcinoma, Prostate Ductal Adenocarcinoma","enrollment":194},{"nctId":"NCT07333300","phase":"NA","title":"Exploratory Clinical Investigation on Neurosensory Responses Via EEG Headband in Adults With Mild to Moderate Atopic Dermatitis After Application of Marketed Product Compared With Placebo (Water Application).","status":"NOT_YET_RECRUITING","sponsor":"NovoBliss Research Pvt Ltd","startDate":"2026-01-04","conditions":"Atopic Dermatitis (AD)","enrollment":20},{"nctId":"NCT05224336","phase":"PHASE1","title":"Psilocybin-assisted Therapy for Phantom Limb Pain","status":"COMPLETED","sponsor":"University of California, San Diego","startDate":"2022-10-03","conditions":"Phantom Limb Pain","enrollment":10},{"nctId":"NCT06217939","phase":"NA","title":"Early Intravenous Hydrocortisone in Sepsis","status":"RECRUITING","sponsor":"Siriraj Hospital","startDate":"2024-06-25","conditions":"Sepsis Severe, Shock, Septic","enrollment":230},{"nctId":"NCT07320937","phase":"NA","title":"Effects of Yiqi Fuyuan Paste Formula in Chronic Fatigue Syndrome: A Randomized Double-Blind Controlled Clinical Trial.","status":"ENROLLING_BY_INVITATION","sponsor":"ShuGuang Hospital","startDate":"2025-12-29","conditions":"CFS","enrollment":80},{"nctId":"NCT06429163","phase":"NA","title":"Pre-incisional Wound INfiltration and Hypogastric PLEXus Block Using Ropivacaine in Laparoscopic Myomectomy","status":"COMPLETED","sponsor":"Saint Petersburg State University, Russia","startDate":"2024-05-14","conditions":"Fibroid Uterus, Pain, Postoperative","enrollment":207},{"nctId":"NCT05080569","phase":"PHASE4","title":"Luteal Phase Support in IUI MOH Treatment Luteal Phase Support in IUI MOH Treatment","status":"RECRUITING","sponsor":"UMC Utrecht","startDate":"2023-03-01","conditions":"Pregnancy Related, Fertility Issues, Luteal Phase Defect","enrollment":1008},{"nctId":"NCT05691244","phase":"PHASE3","title":"Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke","status":"RECRUITING","sponsor":"Pharmazz, Inc.","startDate":"2025-07-24","conditions":"Acute Ischemic Stroke, Cerebral Stroke","enrollment":514},{"nctId":"NCT03199885","phase":"PHASE3","title":"Testing the Drug Atezolizumab or Placebo With Usual Therapy in First-Line HER2-Positive Metastatic Breast Cancer","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2019-04-05","conditions":"Metastatic Breast Adenocarcinoma, Metastatic HER2-Positive Breast Carcinoma, Recurrent Breast Adenocarcinoma","enrollment":190},{"nctId":"NCT07308184","phase":"PHASE3","title":"Bridge Study to Evaluate the Efficacy and Safety of IN-B00009 Injection in Patients With T2DM Inadequately Controlled by Diet and Exercise Alone","status":"NOT_YET_RECRUITING","sponsor":"HK inno.N Corporation","startDate":"2025-12","conditions":"Diabetes (DM), Diabetes Mellitus Type 2","enrollment":110},{"nctId":"NCT07304024","phase":"PHASE1, PHASE2","title":"A Treatment for a Form of Age-Related Central Auditory Processing Disorder Consisting of Clemastine Fumarate Plus Engineered Sound","status":"RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2025-12-15","conditions":"Central Auditory Processing Disorder, Hearing Impaired (Partially), Hearing","enrollment":344},{"nctId":"NCT06040190","phase":"PHASE4","title":"Effect of Treatments on Pain and Quality of Life in Individual With Burning Mouth Syndrome","status":"RECRUITING","sponsor":"Federal University of Minas Gerais","startDate":"2023-11-01","conditions":"Burning Mouth Syndrome","enrollment":150},{"nctId":"NCT07300813","phase":"NA","title":"Olistic_2025 for Hair Loss, Hair Growth, and Skin Improvement","status":"ACTIVE_NOT_RECRUITING","sponsor":"Bionos Biotech S.L.","startDate":"2025-10-20","conditions":"Hair Care, Hair Loss, Female Pattern Hair Loss","enrollment":100},{"nctId":"NCT03828344","phase":"PHASE1","title":"Safety and Tolerability of a Single Intravenous Infusion of BX-U001 in Refractory Rheumatoid Arthritis","status":"NOT_YET_RECRUITING","sponsor":"Baylx Inc.","startDate":"2026-12-01","conditions":"Rheumatoid Arthritis","enrollment":16},{"nctId":"NCT05845645","phase":"PHASE1","title":"A Study to Test Bioavailability of of 2 New Formulations of UCB0599 in Healthy Participants in Part A and to Test Safety, Tolerability, and Pharmacokinetic (PK) of UCB0599 in Healthy Japanese and Chinese Participants in Part B","status":"COMPLETED","sponsor":"UCB Biopharma SRL","startDate":"2023-05-31","conditions":"Healthy Study Participants","enrollment":73},{"nctId":"NCT02144584","phase":"EARLY_PHASE1","title":"Memantine for Enhanced Stroke Recovery","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Utah","startDate":"2014-01","conditions":"Ischemic Stroke, Upper Extremity Weakness","enrollment":20},{"nctId":"NCT07295418","phase":"PHASE3","title":"A Study of SAL003 in Participants With Hypercholesterolemia and Mixed Dyslipidemia","status":"COMPLETED","sponsor":"Shenzhen Salubris Pharmaceuticals Co., Ltd.","startDate":"2023-10-23","conditions":"Hyperlipidemias","enrollment":618},{"nctId":"NCT05874037","phase":"PHASE2, PHASE3","title":"Fluvoxamine for Long COVID-19","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2023-05-15","conditions":"Long COVID","enrollment":191},{"nctId":"NCT06560333","phase":"PHASE3","title":"iSGLT2 Inhibitor and a iDPP -4 Inhibitor in Treatment of Type 2 Diabetes Mellitus in Patients Treated With Metformin (TRIAD)","status":"WITHDRAWN","sponsor":"Eurofarma Laboratorios S.A.","startDate":"2026-11-30","conditions":"Diabetes Mellitus, Type 2","enrollment":""},{"nctId":"NCT06742957","phase":"PHASE3","title":"Study Comparing Tapinarof Cream 1% To VTAMA ® (Tapinarof Cream 1%) In the Treatment of Plaque Psoriasis","status":"COMPLETED","sponsor":"Teva Pharmaceuticals USA","startDate":"2024-12-17","conditions":"Plaque Type Psorisis","enrollment":560},{"nctId":"NCT07289178","phase":"PHASE1, PHASE2","title":"Effect of Liposome Bupivacaine Serratus Plane Block on Postoperative Hyperalgesia and Chronic Post-surgical Pain in Patients Undergoing Radical Mastectomy","status":"NOT_YET_RECRUITING","sponsor":"First Affiliated Hospital of Kunming Medical University","startDate":"2026-01-01","conditions":"Serratus Plane Block, Postoperative Hyperalgesia, Chronic Post-surgical Pain","enrollment":120},{"nctId":"NCT07206407","phase":"NA","title":"Clinical Trial on Rapid Immune Modulating Effects","status":"RECRUITING","sponsor":"Natural Immune Systems Inc","startDate":"2025-09-28","conditions":"Immune Surveillance","enrollment":24},{"nctId":"NCT05660850","phase":"PHASE2","title":"A Study To Evaluate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamic Effects Of GDC-6599 In Patients With Chronic Cough","status":"COMPLETED","sponsor":"Genentech, Inc.","startDate":"2023-03-22","conditions":"Chronic Refractory Cough (CRC) With Non-atopic Asthma, CRC With Atopic Asthma, Unexplained Chronic Cough","enrollment":49},{"nctId":"NCT07118085","phase":"PHASE1","title":"A Randomized, Double-blind, Placebo-controlled, Single and Multiple Dose Escalation Phase I Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of IMC-003 for Injection in Healthy Postmenopausal Women","status":"RECRUITING","sponsor":"ImmuneOnco Biopharmaceuticals (Shanghai) Inc.","startDate":"2025-08-18","conditions":"Healthy Postmenopausal Women","enrollment":56},{"nctId":"NCT06614322","phase":"PHASE2","title":"SPENDD: Quantitative Sensory Testing and Analgesic Response for Painful Peripheral Neuropathy.","status":"NOT_YET_RECRUITING","sponsor":"University of Rochester","startDate":"2026-01","conditions":"Painful Peripheral Neuropathy, Diabetic Peripheral Neuropathic Pain (DPN), Chemotherapy Induced Peripheral Neuropathy (CIPN)","enrollment":190},{"nctId":"NCT05850078","phase":"NA","title":"FB101 Intervention in Women Screened to Have Vaginal Dysbiosis (Dyscover-3)","status":"COMPLETED","sponsor":"Freya Biosciences ApS","startDate":"2023-05-18","conditions":"Vaginal Flora Imbalance","enrollment":97},{"nctId":"NCT07073781","phase":"NA","title":"Probiotic Impact on Cognitive Performance, and Metabolic Outcomes in Overweight Young Adults With Impaired Glucose Regulation","status":"RECRUITING","sponsor":"Leeds Beckett University","startDate":"2025-08-15","conditions":"Impaired Glucose Regulation, Impaired Glucose Tolerance (Prediabetes), Prediabetes (Insulin Resistance, Impaired Glucose Tolerance)","enrollment":70},{"nctId":"NCT02408354","phase":"PHASE2","title":"Pilot Study, Comparative, Single-center, Randomized, Crossover, Double-blind, Against Placebo, Testing the Effectiveness of Triheptanoin Oil in Alternating Hemiplegia of Childhood","status":"COMPLETED","sponsor":"Institut National de la Santé Et de la Recherche Médicale, France","startDate":"2015-03-25","conditions":"Alternating Hemiplegia of Childhood","enrollment":10},{"nctId":"NCT07268573","phase":"NA","title":"Effects of Caffeine and L-Theanine on Physical and Cognitive Performance in Trained Athletes","status":"COMPLETED","sponsor":"Ulaş Can YILDIRIM","startDate":"2025-08-01","conditions":"Cognitive Performance, Physical Performance Enhancement, Caffeine and L-theanine Interaction","enrollment":20},{"nctId":"NCT06312657","phase":"EARLY_PHASE1","title":"Behavioral Effects of Drugs Inpatient 44 Neurobehavioral Mechanisms of Opioid Choice","status":"TERMINATED","sponsor":"Joshua A. Lile, Ph.D.","startDate":"2023-03-01","conditions":"Opioid Use Disorder","enrollment":2},{"nctId":"NCT05136170","phase":"PHASE3","title":"Study to Evaluate Safety and Efficacy of Cenegermin (Oxervate®) vs Vehicle in Severe Sjogren's Dry Eye Disease","status":"COMPLETED","sponsor":"Dompé Farmaceutici S.p.A","startDate":"2022-01-27","conditions":"Dry Eye Disease","enrollment":85}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":108,"recentPublications":[{"date":"2025 Nov","pmid":"41184148","title":"SHPro(®) (mixture of Angelica gigas and Astragalus membranaceus) in men with lower urinary tract symptoms: A randomized, double-blind, placebo-controlled clinical trial.","journal":"Investigative and clinical urology"},{"date":"2025 Sep 11","pmid":"40935395","title":"Skin Anti-Aging and Moisturizing Effects of Low-Molecular-Weight Collagen Peptide Supplementation in Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.","journal":"Journal of microbiology and biotechnology"},{"date":"2025 Dec","pmid":"40883125","title":"Lowering plasma S-Adenosylhomocysteine (SAH) in healthy adults with elevated SAH and normal homocysteine using nutritional supplementation.","journal":"Nutrition, metabolism, and cardiovascular diseases : NMCD"},{"date":"2025 Jun 25","pmid":"40561520","title":"Impact of Fortified Malt-Based Food on Immunity Outcomes in School Children in India: Cluster Randomized Controlled Trial.","journal":"Interactive journal of medical research"},{"date":"2025 Apr 22","pmid":"40263513","title":"ACE inhibitory casein peptide lowers blood pressure and reshapes gut microbiota in a randomized double blind placebo controlled trial.","journal":"Scientific reports"}],"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Placebo inhaler containing HFA propellant resembling the test active inhaler"],"phase":"phase_3","status":"active","brandName":"Placebo of Test product","genericName":"Placebo of Test product","companyName":"FLUIDDA nv","companyId":"fluidda-nv","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}